RESAT CINAR (@resatcinar) profile picture

Scientist, pharmacist, pharmacologist, researching on cannabinoids, endocannabinoids, and pulmonary fibrosis. fibrosis researcher. —opinions are my own views.

Maryland, USA
Joined July 2012
Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)Photo by RESAT CINAR (@resatcinar)
🚀 Postdoc Opportunity in Systems Biology @NIH (NIAAA) Join our collaborative team studying fibrosis using cutting-edge multi-omics & spatial biology approaches. 📍 Bethesda, MD, USA 
🔗 training.nih.gov/jobs/pd-080… #Postdoc #Bioinformatics #SystemsBiology #Omics #NIH
10
1
21
2,077
✨Exciting to see clinical efficacy of peripheral #CB1R antagonism with #monlunabant. It will expand armamentarium for #obesity with a different mechanism than incretins (#GLP1 #GIP) ⚡️Similar efficacies in all tested oral doses encourage testing lower doses to optimize safety.
Efficacy and safety of #monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial thelancet.com/journals/landi… #obesity #MetabolicSyndrome
1
4
206
📣Our research @JCI_Insight highlights the key role of #cannabinoid receptor 1 (#CB1R) in #AlveolarMacrophages in promoting #PulmonaryFibrosis. We propose that pulmonary delivery of #zevaquanabant as an effective and safer therapeutic approach for PF insight.jci.org/articles/vie…
3
5
20
1,243
🧵6️⃣ 📌 #Zevaquenabant treatment effectively reduces #fibrosis in human precision-cut lung slices (#hPCLS). 📌 Pulmonary delivery of zevaquenabant may offer a more targeted and safer #therapeutic modality for #fibrotic #lung #diseases
1
3
105
🧵7️⃣ Our research exemplifies amazing team and collaborative effort (@m_konigshoff lab)! Big shout out to @abhishekbasu86 @muharif #antifibrotic #TherapeuticDiscovery #DrugDiscovery #PulmonaryFibrosis #CurePF #CureHPS #CB1R
4
72
‼️A post-doc position available in my lab at the NIH ‼️ ⚡️Fibrosis Biology ⚡️Biomarker Discovery ⚡️Pharmacology ⚡️Therapeutic discovery ⚡️Translational research See the position details👇 training.nih.gov/jobs/pdf-09… #postdoc #Fibrosis #pulmonaryfibrosis #RareDisease Please RT
11
1
18
2,539
Our research shows anandamide in blood has biomarker functions in Hermansky-Pudlak syndrome. It not only captures early stage fibrosis progression in lung but also informs on therapeutic effect for CB1R antagonism.This may help to design effective anti-fibrotic therapy @CureHPS
Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis This study suggests that circulating anandamide levels begin to increase with the fibrotic lung process even at subclinical stages @resatcinar @IRPatNIH 🔗 tinyurl.com/2p9nrru7
4
171
📣 New Hurd Lab paper in @molpsychiatry explores how cannabidiol (#CBD) can help reduce anxiety linked to specific triggers. Learn more about our findings 🧵 and read the full paper: nature.com/articles/s41380-0… (1/7)
1
12
1
39
2,097
Congrats to @pommerollelenny and @ctm_dijon team for this impactful work! This work not only endorsed CD206 expressing macrophages as a profibrotic macrophages in progressive #pulmonaryfibrosis but also elegantly provides an imaging tool to use biomarker function of CD206 imaging
This Post is from an account that no longer exists. Learn more
4
259
Our preprint presents #endocannabinoid #anandamide (#CB1R agonist) in blood has both early disease #biomarker and surrogate marker functions in Hermansky Pudlak syndrome pulmonary #fibrosis (#HPSPF) @HPSNetwork
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis medrxiv.org/cgi/content/shor… #medRxiv
1
1
2
302
#CB1R antagonism reversed circulating #AEA in serum and attenuated progression of pulmonary fibrosis in the experimental model of HpsPF.
1
1
105
The blood biomarker functions of #Anandamide may help targeted prophylactic or early therapeutic interventions in a highly predictable fibrosing #rarelungdisease #HPSPF in the future.
92
19 Mayıs’ta gençler ve bilim tutkunları ile #bioinfocongress de buluşmayı heyecanla bekliyorum. Sizlerle kendi bilimsel serüvenimi ve laboratuvardan kliniğe ulaşan bir ilaç geliştirme hikayesini paylaşacağım. @bioinforange #obezite #diyabet #fibrozis #farmakoloji
#Bioinfocongress VI kapsamında, 19 Mayıs 2024 tarihinde 16.30-17.30 saatleri arasında Sayın Dr. Reşat Çınar "Metabolik Hastalıklar için Kannabinoid Reseptörleri Hedef Alan Bir ilaç Geliştirme Hikayesi“ konulu konuşmasını gerçekleştirecektir. 🔗Kayıt linki: bioinforange.com/bioinfocong… #kanser #cancer #metastaz #Cannabissativa #ilaç #farmakoloji #kannabinoid #tıp #hastalık #tedavi #biyoloji #AcademicChatter #AcademicTwitter #bilimlekalalım
2
202